These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22568183)

  • 1. [Acute kidney injury (AKI) requireing renal replacement therapy in a patient treated with intravenous immunoglobulin].
    Wojtecka A; Kade G; Bilbin-Bukowska A; Niemczyk S
    Pol Merkur Lekarski; 2012 Mar; 32(189):173-5. PubMed ID: 22568183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic inflammatory demyelinating polyneuropathy and sarcoidosis: fortuitous association?].
    Ducray F; Costedoat-Chalumeau N; Bouhour F; Rousset H; Vial C
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S85-9. PubMed ID: 18087235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.
    Jasmin R; Sockalingam S; Shahrizaila N; Cheah TE; Zain AA; Goh KJ
    Lupus; 2012 Sep; 21(10):1119-23. PubMed ID: 22433918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
    Vina ER; Fang AJ; Wallace DJ; Weisman MH
    Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammatory demyelinating polyneuropathy associated with intestinal tuberculosis.
    Chong VH; Joseph TP; Telisinghe PU; Jalihal A
    J Microbiol Immunol Infect; 2007 Aug; 40(4):377-80. PubMed ID: 17712474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of renal function after intravenous immunoglobulin.
    Soares SM; Sethi S
    Nephrol Dial Transplant; 2006 Mar; 21(3):816-7. PubMed ID: 16399766
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic inflammatory demyelinating polyneuropathy in a diabetic patient: deterioration after intravenous immunoglobulins treatment and favorable response to steroid treatment.
    Pedersen K; Pandolfo M; Mavroudakis N
    Acta Neurol Belg; 2007 Mar; 107(1):14-7. PubMed ID: 17569228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulatory effects on axonal function after intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
    Lin CS; Krishnan AV; Park SB; Kiernan MC
    Arch Neurol; 2011 Jul; 68(7):862-9. PubMed ID: 21747028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous immunoglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathy.
    Lee DH; Linker RA; Paulus W; Schneider-Gold C; Chan A; Gold R
    Muscle Nerve; 2008 Mar; 37(3):406-9. PubMed ID: 17918749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the best initial treatment for childhood chronic inflammatory demyelinating polyneuropathy: corticosteroids or intravenous immunoglobulin?
    Sladky JT
    Muscle Nerve; 2008 Dec; 38(6):1638-43. PubMed ID: 19016535
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy.
    Rajabally YA
    Muscle Nerve; 2015 May; 51(5):657-61. PubMed ID: 25556954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
    Cocito D; Ciaramitaro P; Isoardo G; Barbero P; Migliaretti G; Pipieri A; Proto G; Quadri R; Bergamasco B; Durelli L
    J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of axonal function in patients with chronic inflammatory demyelinating polyneuropathy after intravenous immunoglobulin therapy.
    Hughes RA; Mills K
    Arch Neurol; 2011 Jul; 68(7):844-6. PubMed ID: 21747026
    [No Abstract]   [Full Text] [Related]  

  • 14. Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report.
    Alexander KJ; Alshubaili AF; Santhamoorthy P; Sharafuddin KM
    Med Princ Pract; 2008; 17(5):422-4. PubMed ID: 18685286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical condition of chronic inflammatory demyelinating polyneuropathy (CIDP).
    Phillips LH
    Muscle Nerve; 2009 Apr; 39(4):v-vii. PubMed ID: 19418620
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
    Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
    Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus.
    Münch C; Anagnostou P; Meyer R; Haas J
    J Neurol Sci; 2007 May; 256(1-2):100-2. PubMed ID: 17382963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of Immunoglobulin Therapy and Implications for Treatment of Inflammatory Neuropathy: A Review.
    Abbas A; Rajabally YA
    Curr Drug Saf; 2019; 14(1):3-13. PubMed ID: 30332974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual patients who experienced both Guillain-Barré syndrome and CIDP.
    Kuitwaard K; van der Pol WL; Ruts L; van Doorn PA
    J Peripher Nerv Syst; 2009 Mar; 14(1):66-8. PubMed ID: 19335542
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic inflammatory demyelinating polyneuropathy in a patient with hyperIgEaemia.
    Kimura A; Yoshino H; Yuasa T
    J Neurol Sci; 2005 Apr; 231(1-2):89-93. PubMed ID: 15792827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.